Literature DB >> 1827527

On the selection of mice for haloperidol response and non-response.

R Hitzemann1, K Dains, C M Bier-Langing, N R Zahniser.   

Abstract

Mice have been selected over eight generations for response and non-response to haloperidol-induced catalepsy. The selection has been asymmetric, with significantly faster divergence for the haloperidol non-responder (HNR) line as compared to the haloperidol responder (HR) line. After six generations of selection, the ED50 in the HNR line was 4.3 mg/kg and 0.4 mg/kg in the HR line. Spiroperidol, fluphenazine and trifluoperazine showed a 10-fold or greater discrimination between lines. Raclopride, a specific dopamine D2 antagonist, showed a 7-fold discrimination between lines. Chlorpromazine, thiothixene, (+) butaclamol and cis-flupenthixol showed a 3-4-fold discrimination between lines. The specific D1 antagonist, SCH 23390, was the most potent cataleptogenic agent tested (ED50 = 0.1 mg/kg) and did not discriminate between the lines. The HR and HNR lines did not differ in post-synaptic D2 receptor affinity or density as assessed by quantitative receptor autoradiography and membrane binding assays. However, A-9 somatodendritic receptor density was 80% higher in the HNR line as compared to the HR line.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827527     DOI: 10.1007/bf02244211

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

1.  Messenger RNA encoding the D2 dopaminergic receptor detected by in situ hybridization histochemistry in rat brain.

Authors:  A Najlerahim; A J Barton; P J Harrison; J Heffernan; R C Pearson
Journal:  FEBS Lett       Date:  1989-09-25       Impact factor: 4.124

2.  A neuroendocrine study of supersensitivity in tardive dyskinesia.

Authors:  C A Tamminga; R C Smith; G Pandey; L A Frohman; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1977-10

3.  Short-term outcome in trial entrants and trial eligible patients.

Authors:  J F MacMillan; T J Crow; A L Johnson; E C Johnstone
Journal:  Br J Psychiatry       Date:  1986-02       Impact factor: 9.319

Review 4.  Two dopamine receptors: biochemistry, physiology and pharmacology.

Authors:  J C Stoof; J W Kebabian
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

5.  Bidirectional selection for susceptibility to ethanol withdrawal seizures in Mus musculus.

Authors:  J C Crabbe; A Kosobud; E R Young; B R Tam; J D McSwigan
Journal:  Behav Genet       Date:  1985-11       Impact factor: 2.805

6.  Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.

Authors:  R H Roth; L C Murrin; J R Walters
Journal:  Eur J Pharmacol       Date:  1976-03       Impact factor: 4.432

7.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

8.  Plasma catecholamine metabolites and early response to haloperidol.

Authors:  M B Bowers; M E Swigar; P I Jatlow; N Goicoechea
Journal:  J Clin Psychiatry       Date:  1984-06       Impact factor: 4.384

9.  Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase.

Authors:  F Filloux; T M Dawson; J K Wamsley
Journal:  Brain Res Bull       Date:  1988-04       Impact factor: 4.077

10.  Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys.

Authors:  E K Richfield; A B Young; J B Penney
Journal:  J Comp Neurol       Date:  1987-08-15       Impact factor: 3.215

View more
  3 in total

1.  Gene networks and haloperidol-induced catalepsy.

Authors:  O D Iancu; P Darakjian; B Malmanger; N A R Walter; S McWeeney; R Hitzemann
Journal:  Genes Brain Behav       Date:  2011-11-11       Impact factor: 3.449

2.  Stimulation of the immune response during activation of the dopaminergic system in mice with opposite types of behavior.

Authors:  G V Idova; M A Cheido; E N Zhukova; L V Devoino
Journal:  Neurosci Behav Physiol       Date:  2004-05

3.  Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice.

Authors:  Glenn W Stevenson; Jim Cormier; Hannah Mercer; Chloe Adams; Catherine Dunbar; S Stevens Negus; Edward J Bilsky
Journal:  Life Sci       Date:  2009-06-24       Impact factor: 5.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.